Perrigo Ordinary Shares reported $362.9M in Gross Profit on Sales for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Abbott ABT:US USD 5.5B 283M
Bayer BAYN:GR EUR 7.03B 105M
Bristol Myers Squibb BMY:US USD 8.86B 345M
Catalent CTLT:US USD 258M 230M
Corcept Therapeutics CORT:US USD 100.39M 1.68M
Dr.Reddys Laboratories DRRD:IN INR 47.88B 3.04B
Eli Lilly And LLY:US USD 5.36B 305M
Endo International Ordinary Shares ENDP:US USD 364.83M 28.49M
Horizon Pharma HZNP:US USD 691.23M 45.03M
Johnson & Johnson JNJ:US USD 15.94B 56M
Merk MRK:US USD 11.08B 635M
Nestle NESN:VX 20.95B 317M
Pacira Pharmaceuticals PCRX:US USD 116.79M 2M
Perrigo Ordinary Shares PRGO:US USD 362.9M 9.2M
Pfizer PFE:US USD 14.47B 2.08B
Prestige Brands PBH:US USD 161.01M 890K
Reckitt Benckiser Group PLC RB/:LN GBP 4B 141M
Teva Pharmaceutical TEVA:IT USD 1.71B 118M
Xeris Pharmaceuticals Inc XERS:US USD 24.46M 3.97M
Zoetis ZTS:US USD 1.4B 36M